Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis
- PMID: 16392792
- DOI: 10.1021/jm050363f
Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis
Abstract
To gain insight into the structural determinants for the matrix metalloproteinase (MMP) family, we characterized the binding sites of 56 MMP structures and one TACE (tumor necrosis factor alpha converting enzyme) structure using molecular interaction fields (MIFs). These MIFs were produced by two approaches: the GRID force field and the knowledge-based potential DrugScore. The subsequent statistical analysis using consensus principal component analysis (CPCA) for the entire binding site and each subpockets revealed both approaches to encode similar information about discriminating regions. However, the relative importance of the probes varied between both approaches. The CPCA models provided the following ranking of the six subpockets based on the opportunity for selective interactions with different MMPs: S1' > S2, S3, S3' > S1, S2'. The interpretation of these models agreed with experimental binding modes inferred from crystal structures or docking.
Similar articles
-
A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-alpha converting enzyme: implications for selectivity.J Med Chem. 2005 Apr 7;48(7):2361-70. doi: 10.1021/jm0491703. J Med Chem. 2005. PMID: 15801829 Free PMC article.
-
Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.Bioorg Med Chem. 2007 Sep 15;15(18):6170-81. doi: 10.1016/j.bmc.2007.06.031. Epub 2007 Jun 20. Bioorg Med Chem. 2007. PMID: 17606376
-
Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors: Part I--discovery of two binding modes.J Med Chem. 2008 Feb 28;51(4):725-36. doi: 10.1021/jm070376o. Epub 2008 Feb 5. J Med Chem. 2008. PMID: 18247549
-
The application of x-ray, NMR, and molecular modeling in the design of MMP inhibitors.Curr Top Med Chem. 2004;4(12):1311-27. doi: 10.2174/1568026043387999. Curr Top Med Chem. 2004. PMID: 15320728 Review.
-
Specificity of binding with matrix metalloproteinases.Exp Suppl. 2012;103:35-56. doi: 10.1007/978-3-0348-0364-9_2. Exp Suppl. 2012. PMID: 22642189 Review.
Cited by
-
Synthesis of N-H Bearing Imidazolidinones and Dihydroimidazolones Using Aza-Heck Cyclizations.Angew Chem Int Ed Engl. 2018 Sep 10;57(37):12081-12085. doi: 10.1002/anie.201806295. Epub 2018 Aug 19. Angew Chem Int Ed Engl. 2018. PMID: 30125443 Free PMC article.
-
Prediction of MMP-9 inhibitory activity of N-hydroxy-α-phenylsulfonylacetamide derivatives by pharmacophore based modeling and 3-D QSAR studies.Porto Biomed J. 2018 Jul 3;3(1):e6. doi: 10.1016/j.pbj.0000000000000006. eCollection 2018 Aug. Porto Biomed J. 2018. PMID: 31595232 Free PMC article.
-
Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.Drugs. 2010 May 28;70(8):949-64. doi: 10.2165/11318390-000000000-00000. Drugs. 2010. PMID: 20481653 Review.
-
Analysis of X-ray structures of matrix metalloproteinases via chaotic map clustering.BMC Bioinformatics. 2010 Oct 8;11:500. doi: 10.1186/1471-2105-11-500. BMC Bioinformatics. 2010. PMID: 20932281 Free PMC article.
-
Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.ACS Med Chem Lett. 2014 Sep 23;5(11):1213-8. doi: 10.1021/ml500210x. eCollection 2014 Nov 13. ACS Med Chem Lett. 2014. PMID: 25408833 Free PMC article.
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Chemical Information
Miscellaneous